Member access

4-Traders Homepage  >  Shares  >  Copenhagen Stock Exchange  >  Novo Nordisk A/S    NOVO.B   DK0060534915

NOVO NORDISK A/S (NOVO.B)

126
SummaryChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Develops, manufactures, markets and distributes pharmaceutical products

Novo Nordisk AS is engaged in the development, manufacture, and marketing of pharmaceutical products.

It operates through the Diabetes Care and Biopharmaceuticals segments.

The Diabetes Care segment deals with the research, development, manufacture, and marketing of products within the areas of insulin, glucagon-like-peptide 1 and related delivery systems, oral anti-diabetic products, and obesity.

The Biopharmaceuticals segment handles the research, development, manufacture, and distribution of products within the areas of haemophilia, growth hormone, hormone replacement, inflammation and other therapy areas.

The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Sales per Businesses
20122013Delta
DKK (in Million)%DKK (in Million)%
Diabetes Care60,88778%65,45678.3% +6.98%
Biopharmaceuticals17,13922%18,11621.7% +5.39%
Unallocated-----
Sales per Regions
20122013Delta
DKK (in Million)%DKK (in Million)%
North America34,22043.9%39,02446.7% +12.31%
Europe19,70725.3%20,06324% +1.77%
Int'l Operations11,08014.2%12,00714.4% +7.72%
Japan & Korea6,6178.5%5,3176.4% -24.45%
China6,4028.2%7,1618.6% +10.6%
Surperformance© rating of Novo Nordisk A/S
Overall rating In sector In country
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
PER
Potential
Yield
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
More Ratings
Sector
Healthcare
Biotechnology / Pharmaceuticals
 Biotechnology / Pharmaceuticals
  Pharmaceuticals - Diversified
Advertisement
Sector Pharmaceuticals - Diversified
Trading RatingInvestor Rating
JOHNSON & JOHNSON
ROCHE HOLDING LTD..
NOVARTIS AG
PFIZER INC.
MERCK & CO., INC.
Sector Pharmaceuticals - Diversified
Company contact information
Novo Nordisk A/S
Novo Allé
Bagsværd 2880

Phone : +45.44.44.88.88
Fax : +45.44.49.05.55
Web : www.novonordisk.com
© 2014 Factset   
Dynamic quotes  
ON
| OFF